These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 12538468
1. Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications. Micke P, Basrai M, Faldum A, Bittinger F, Rönnstrand L, Blaukat A, Beeh KM, Oesch F, Fischer B, Buhl R, Hengstler JG. Clin Cancer Res; 2003 Jan; 9(1):188-94. PubMed ID: 12538468 [Abstract] [Full Text] [Related]
2. Coexpression of fragile histidine triad and c-kit is relevant for prediction of survival in patients with small cell lung cancer. Rehfeld N, Geddert H, Atamna A, Gabbert HE, Steidl U, Fenk R, Kronenwett R, Haas R, Rohr UP. Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2232-8. PubMed ID: 17119051 [Abstract] [Full Text] [Related]
8. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis. Yaren A, Oztop I, Kargi A, Ulukus C, Onen A, Sanli A, Binicier O, Yilmaz U, Alakavuklar M. Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752 [Abstract] [Full Text] [Related]
11. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. Krystal GW, Hines SJ, Organ CP. Cancer Res; 1996 Jan 15; 56(2):370-6. PubMed ID: 8542594 [Abstract] [Full Text] [Related]
12. Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer. Wolff NC, Randle DE, Egorin MJ, Minna JD, Ilaria RL. Clin Cancer Res; 2004 May 15; 10(10):3528-34. PubMed ID: 15161712 [Abstract] [Full Text] [Related]
13. Kit expression in small cell carcinomas of the lung: effects of chemotherapy. Rossi G, Cavazza A, Marchioni A, Migaldi M, Bavieri M, Facciolongo N, Petruzzelli S, Longo L, Tamberi S, Crinò L. Mod Pathol; 2003 Oct 15; 16(10):1041-7. PubMed ID: 14559988 [Abstract] [Full Text] [Related]
14. Increased expression of integrin beta1 is a poor prognostic factor in small-cell lung cancer. Oshita F, Kameda Y, Ikehara M, Tanaka G, Yamada K, Nomura I, Noda K, Shotsu A, Fujita A, Arai H, Ito H, Nakayama H, Mitsuda A. Anticancer Res; 2002 Oct 15; 22(2B):1065-70. PubMed ID: 12168902 [Abstract] [Full Text] [Related]
15. [Clinicopathological significance of expression of c-kit protein in neuroendocrine lung carcinoma]. Zhao P, Hou N, Shao Y, Li XH. Zhonghua Yi Xue Za Zhi; 2005 Jun 15; 85(22):1526-9. PubMed ID: 16179109 [Abstract] [Full Text] [Related]
16. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer. Park JY, Lee WK, Jung DK, Choi JE, Park TI, Lee EB, Cho S, Park JY, Cha SI, Kim CH, Kam S, Jung TH, Jheon S. Clin Cancer Res; 2009 Mar 01; 15(5):1794-800. PubMed ID: 19240174 [Abstract] [Full Text] [Related]
17. Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer. Chang MH, Lee J, Han J, Park YH, Ahn JS, Park K, Ahn MJ. APMIS; 2009 Dec 01; 117(12):861-9. PubMed ID: 20078550 [Abstract] [Full Text] [Related]
18. Phase II study of imatinib in patients with small cell lung cancer. Johnson BE, Fischer T, Fischer B, Dunlop D, Rischin D, Silberman S, Kowalski MO, Sayles D, Dimitrijevic S, Fletcher C, Hornick J, Salgia R, Le Chevalier T. Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5880-7. PubMed ID: 14676110 [Abstract] [Full Text] [Related]